Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Assets (2016 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Return on Assets for 9 consecutive years, with 0.3% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 87.0% year-over-year to 0.3%, compared with a TTM value of 0.3% through Dec 2025, up 87.0%, and an annual FY2025 reading of 0.36%, up 96.0% over the prior year.
  • Return on Assets was 0.3% for Q4 2025 at Zevra Therapeutics, up from 0.13% in the prior quarter.
  • Across five years, Return on Assets topped out at 82.69% in Q3 2022 and bottomed at 0.57% in Q4 2024.
  • Average Return on Assets over 5 years is 3.91%, with a median of 0.26% recorded in 2023.
  • The sharpest move saw Return on Assets skyrocketed 8277bps in 2022, then plummeted -8288bps in 2023.
  • Year by year, Return on Assets stood at 0.06% in 2021, then tumbled by -615bps to 0.45% in 2022, then grew by 29bps to 0.32% in 2023, then tumbled by -79bps to 0.57% in 2024, then surged by 153bps to 0.3% in 2025.
  • Business Quant data shows Return on Assets for ZVRA at 0.3% in Q4 2025, 0.13% in Q3 2025, and 0.01% in Q2 2025.